Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class III drug recalls - low risk

Class III means the product is unlikely to cause harm but violates FDA labeling or manufacturing rules. These are the recalls you rarely hear about; pharmacies usually just swap the affected lot.

1,716 recalls, newest first.

Class III · Low risk

Tecfidera (dimethyl fumarate)

cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Terminated cGMP deviation Biogen MA Inc. NDC 64406-006-02 D-1381-2020
Class III · Low risk

Nystatin Oral Suspension

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

Terminated Impurity / degradation VistaPharm, Inc. NDC 66689-008-16 D-1378-2020
Class III · Low risk

Nystatin Oral Suspension

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

Terminated Impurity / degradation VistaPharm, Inc. NDC 66689-037-50 D-1377-2020
Class III · Low risk

Famotidine Injection

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Terminated Temperature excursion HF Acquisition Co. LLC NDC 63323-739-12 D-1392-2020
Class III · Low risk

Nabumetone Tablets

Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.

Terminated Labeling / mix-up American Health Packaging D-1372-2020
Class III · Low risk

Brimonidine Tartrate Opthalmic Solution 0.2%

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Terminated Impurity / degradation Somerset Therapeutics LLC NDC 70069-233-01 D-1375-2020
Class III · Low risk

Brimonidine Tartrate Opthalmic Solution 0.2%

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Terminated Impurity / degradation Somerset Therapeutics LLC NDC 70069-232-01 D-1374-2020
Class III · Low risk

Brimonidine Tartrate Opthalmic Solution 0.2%

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Terminated Impurity / degradation Somerset Therapeutics LLC NDC 70069-231-01 D-1373-2020
Class III · Low risk

Clonidine Hydrochloride Tablets

Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.

Terminated Impurity / degradation Unichem Pharmaceuticals USA INC NDC 29300-135-01 D-1291-2020
Class III · Low risk

Lamotrigine Tablets

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Terminated Particulate / foreign matter Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-247-97 D-1281-2020
Class III · Low risk

Gabapentin Tablets USP

Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.

Terminated Impurity / degradation InvaGen Pharmaceuticals, Inc. NDC 76282-405-05 D-1272-2020

Recalls by year